Ideaya and Hengrui report promising data for DLL3-targeted cancer drug

Ideaya and Hengrui report promising data for DLL3-targeted cancer drug

Related Posts

Carvana gets a spot in the S&P 500 ahead of these tech stocks

Carvana gets a spot in the S&P 500 ahead of these tech ...

I tried to donate my crypto to charity. Here’s what I learned.

I tried to donate my crypto to charity. Here’s what I l...

SpaceX may be worth more than half of Tesla — with a sixth of the revenue

SpaceX may be worth more than half of Tesla — with a si...

What does Netflix’s offer to buy HBO Max mean for you?

What does Netflix’s offer to buy HBO Max mean for you?

The Fed is running into a wall of its own making ahead of next week’s interest-rate vote

The Fed is running into a wall of its own making ahead ...

Adaptive Biotechnologies CSO Robins sells $672,515 in ADPT stock

Adaptive Biotechnologies CSO Robins sells $672,515 in A...